Leinco Technologies to develop new COVID-19 diagnostic tools
Industry News: Leinco Technologies partners with leading research organization to develop novel COVID-19 diagnostic tools 09 Mar 2021 La Jolla Institute for Immunology (LJI), one of the leading research organizations dedicated to studying the immune system announced today that it has signed a licensing agreement with Leinco Technologies, Inc., a premier developer, and manufacturer of leading-edge recombinant proteins, antibodies, and conjugates. Leinco also provides custom manufacturing services to the diagnostic and biopharmaceutical industries to leverage proprietary COVID-19 antibodies dev...
Source: selectscience.net